EarningsQ4 2025 Earnings Report

Vir Biotechnology (VIR) Q4 2025 Earnings Report

4 Followers

MX:VIR Q4 2025 EPS Results

Actual EPS-$5.64

Consensus EPS-$8.93

Beat/MissBeat by +$3.29

One Year Ago EPS-$13.82

Actual Revenue$1.16B

Expected Revenue$361.84M

Beat/MissBeat by +$802.84M

YoY Revenue Growth+417.78%

QuarterQ4 2025

Date02/23/2026

TimeAfter Close

Conference CallMonday, February 23, 2026

MX:VIR Upcoming Earnings

Vir Biotechnology's next earnings date is estimated for October 29, 2026, based on past reporting schedules.

MX:VIR Q4 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 29, 2026	2026 (Q3)	-13.43 / -	-21.268	―
Aug 05, 2026	2026 (Q2)	6.05 / 8.54	-14.543	158.75% (+23.09)
May 06, 2026	2026 (Q1)	-1.75 / -15.45	-15.997	3.41% (+0.55)
Feb 23, 2026	2025 (Q4)	-8.93 / -5.64	-13.815	59.21% (+8.18)
Nov 05, 2025	2025 (Q3)	-15.34 / -21.27	-28.358	25.00% (+7.09)
Aug 06, 2025	2025 (Q2)	-13.14 / -14.54	-18.542	21.57% (+4.00)
May 07, 2025	2025 (Q1)	-15.20 / -16.00	-8.726	-83.33% (-7.27)
Feb 26, 2025	2024 (Q4)	-15.85 / -13.82	-15.633	11.63% (+1.82)
Oct 31, 2024	2024 (Q3)	-19.12 / -28.36	-22.177	-27.87% (-6.18)
Aug 01, 2024	2024 (Q2)	-16.27 / -18.54	-26.358	29.66% (+7.82)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed